Vaccine-Preventable Diseases and Epidemiology
Vaccine-preventable diseases (VPDs) are infectious diseases for which a licensed vaccine exists that can prevent infection, disease, or onward transmission. This area surveys the epidemiology of these diseases — how their burden has changed with the introduction of immunization, how vaccination interrupts transmission at the population level, and how surveillance measures progress toward control, elimination, and eradication.
Definition
A vaccine-preventable disease is a communicable disease against which an effective vaccine is available; its epidemiology describes the distribution, determinants, and program-driven trends of that disease in populations before and after vaccine introduction.
Scope
The area orients the reader to the diseases that routine and targeted vaccination programs are designed to prevent, organized by causative agent (viral and bacterial) and by the population-level goals of immunization. It links the biology of individual pathogens to epidemiologic concepts such as herd immunity, vaccination coverage, and the distinction between disease control, elimination, and eradication. It is a reference overview and does not provide schedules or individual immunization advice.
Sub-topics
Core questions
- Which infectious diseases can be prevented by currently available vaccines, and what pathogens cause them?
- How has the morbidity and mortality of these diseases changed since the introduction of immunization?
- How does population-level vaccination interrupt transmission through herd immunity?
- What thresholds and conditions distinguish disease control from elimination and eradication?
Key concepts
- Vaccine-preventable disease (VPD)
- Vaccination coverage
- Basic reproduction number (R0)
- Herd immunity threshold
- Disease control, elimination, and eradication
- Surveillance and case definition
- Pre- versus post-vaccine era burden
Key theories
- Herd immunity
- When a sufficient fraction of a population is immune, the chains of transmission that sustain a pathogen are interrupted, indirectly protecting susceptible individuals; the threshold depends on the basic reproduction number and vaccine effectiveness.
Mechanisms
Vaccines induce immune memory in individuals, reducing the probability that an exposed person becomes infected or transmits the pathogen. At the population level, rising vaccination coverage lowers the effective reproduction number; once enough of the population is immune, sustained transmission becomes impossible and incidence falls, often well below what individual protection alone would predict. The size of this indirect benefit depends on how transmissible the pathogen is and on how well and how durably the vaccine prevents infection and transmission. Surveillance tracks these dynamics, allowing programs to detect outbreaks, measure progress, and identify susceptibility gaps.
Clinical relevance
Understanding which diseases are vaccine-preventable and how their epidemiology has shifted is part of evidence appraisal and public-health literacy in the health sciences. The dramatic declines in morbidity and mortality documented for many of these diseases describe the population impact of immunization programs; this entry characterizes that evidence and is not a basis for individual immunization decisions.
Epidemiology
For many classic VPDs, reported cases in countries with established programs have fallen by roughly 90 percent or more relative to the pre-vaccine era, with comparable declines in deaths and hospitalizations. The magnitude varies by disease and depends on sustained high coverage; declines can reverse where coverage falls or where surveillance weakens, and importation can reseed transmission in partially susceptible populations.
History
The modern concept of a vaccine-preventable disease grew from Jenner's smallpox vaccination and was extended through the twentieth century as vaccines were developed against diphtheria, pertussis, tetanus, polio, measles, and many other agents. Expanded immunization programs from the 1970s onward, together with systematic surveillance, made it possible to quantify the population impact of vaccination and to frame ambitious goals such as the elimination and eradication of specific diseases.
Key figures
- Stanley Plotkin
- Walter Orenstein
- Paul Fine
- Donald Henderson
Related topics
Seminal works
- roush-2007
- fine-1993
- plotkin-2018
Frequently asked questions
- What makes a disease 'vaccine-preventable'?
- A disease is called vaccine-preventable when a licensed, effective vaccine exists that can prevent infection, clinical disease, or transmission of the pathogen that causes it.
- Why does vaccination protect people who are not vaccinated?
- When enough of a population is immune, the pathogen can no longer find a continuous chain of susceptible hosts, so transmission is interrupted and unvaccinated individuals are indirectly protected — the phenomenon of herd immunity.